New Insights 2 York

New Insights 2 York is a SAMHSA-registered addiction-treatment facility in York, PA. The facility's programming is outpatient (IOP), not residential. This page frames the questions that matter most when evaluating a specific program — the ones that separate useful candidates from marginal ones.

Care levels at New Insights 2 York

New Insights 2 York is an outpatient-focused program (IOP) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. ASAM Criteria 4e is the benchmark framework for matching patients to appropriate intensity. Most major payer medical-necessity documents reference it. An outside ASAM-aligned assessment, prior to admission, is the protection against misplacement.

Insurance and payment

New Insights 2 York accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. Before admission, request a written Verification of Benefits from the facility's utilization-review team. Verbal VOB is where most post-admission cost-sharing disputes originate. Written documentation settles them.

Before you call

Three pre-admission questions for New Insights 2 York: (1) at what ASAM 4e level are you admitting me, and what is the clinical rationale; (2) can you provide written Verification of Benefits for my specific plan; (3) what is your MAT policy for opioid use disorder — specifically, do you continue buprenorphine or methadone during residential programming. If the clinical situation involves opioid use disorder, confirm explicitly whether New Insights 2 York offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.